LINC02215

Across TCGA pan-cancer cohorts, LINC02215 RNA is linked to patient survival in 16 of 34 cancer types, making it the most broadly survival-associated LINC02215 data layer.

The strongest signal is observed in uveal melanoma (UVM), where higher LINC02215 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated LINC02215 expression acts as an unfavorable survival marker, although some lineages such as ESCA and STAD show a favorable association.

UVM, LIHC, and THYM are the cancer types where LINC02215 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UVM	DFS	Tertile	All	0.206	0.761	<.001	72	view →
LIHC	OS	Tertile	II,III,IV	0.227	0.634	<.001	72	view →
THYM	DFS	Tertile	All	0.100	0.827	<.001	54	view →
ESCA	DFS	Tertile	II,III,IV	0.588	0.289	.003	54	view →
STAD	OS	Tertile	IV	0.591	0.253	.020	39	view →
BLCA	DFS	Tertile	All	0.397	0.640	.002	33	view →
KIRC	DFS	Tertile	IV	0.226	0.550	.009	27	view →
DLBC	DFS	Tertile	III,IV	0.137	0.761	.014	21	view →
GBM	DFS	Tertile	All	0.103	0.308	.002	18	view →
CESC	DFS	Tertile	II,III,IV	0.488	0.794	.015	18	view →
SARC	OS	Tertile	All	0.642	0.849	.008	15	view →
LUAD	DFS	Tertile	All	0.812	0.650	.037	12	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 16 lineages.

LINC02215–UVM (DFS)

Open the UVM breakdown →